Aemetis (NASDAQ:AMTX – Get Free Report) issued its quarterly earnings data on Tuesday. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09, Zacks reports. The company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same quarter last year, the company earned ($0.59) EPS.
Aemetis Stock Performance
Shares of Aemetis stock traded down $0.32 during trading hours on Wednesday, reaching $4.30. 683,558 shares of the company were exchanged, compared to its average volume of 802,584. The stock’s fifty day moving average is $2.70 and its 200 day moving average is $3.05. The firm has a market cap of $202.96 million, a PE ratio of -3.74 and a beta of 1.23. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on AMTX shares. UBS Group decreased their target price on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th. Ascendiant Capital Markets dropped their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. HC Wainwright reissued a “buy” rating and set a $28.00 target price on shares of Aemetis in a research note on Friday, August 2nd. StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Wednesday, July 31st. Finally, Truist Financial reiterated a “hold” rating and issued a $3.50 price target (down from $4.00) on shares of Aemetis in a research note on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $12.95.
Aemetis Company Profile
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
- Five stocks we like better than Aemetis
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Rocket Lab is the Right Stock for the Right Time
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.